New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:15 EDTWU, ACAD, DVA, FURX, YOKU, AKRX, LGCY, PRGOOn The Fly: Analyst Initiation SummaryWestern Union
Today's noteworthy initiations include: Akorn (AKRX) initiated with a Sector Perform at RBC Capital... DaVita (DVA) initiated with a Market Perform at Bernstein... Perrigo (PRGO) initiated with a Sector Perform at RBC Capital... Youku Tudou (YOKU) initiated with a Buy at Deutsche Bank... ACADIA (ACAD) initiated with an Outperform at Cowen... Furiex (FURX) initiated with a Buy at Canaccord... Legacy Reserves (LGCY) initiated with a Buy at Ladenburg... PBF Energy (WU) initiated with a Buy at Dahlman Rose.
News For AKRX;DVA;PRGO;YOKU;ACAD;LGCY;FURX;WU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 19, 2014
10:12 EDTPRGOHigh option volume stocks
Subscribe for More Information
09:46 EDTLGCYLegacy Reserves downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
December 18, 2014
16:05 EDTDVADaVita appoints Joe Mello as Healthcare Partners COO
Subscribe for More Information
December 17, 2014
16:35 EDTLGCYLegacy Reserves downgraded to Sector Perform from Outperform at RBC Capital
Subscribe for More Information
13:32 EDTPRGOPerrigo jumps after analyst discusses potential takeover by Teva
Subscribe for More Information
09:26 EDTPRGOPerrigo would be good acquisition for Teva, says RBC Capital
RBC Capital views Perrigo (PRGO) as an attractive acquisition target and says in a note to investors that it thinks a takeover could be a good strategic fit with solid accretion for Teva (TEVA). Teva has interest in over-the-counter products and its growth rate would be boosted by the merger, RBC believes. The firm assumes a $200 per share value for Perrigo in its acquisition assumptions. Shares of the over-the-counter and generic pharmaceuticals company closed yesterday at $153.77.
December 16, 2014
10:16 EDTLGCYHigh option volume stocks:
Subscribe for More Information
07:23 EDTLGCYLegacy Reserves downgraded to Neutral from Outperform at RW Baird
Baird slashed upstream MLP estimates across the board given the collapse in crude oil prices. The firm believes upstream MLPs will be forced to cut distributions based on when debt covenants are tripped if oil prices do not rally. Baird expects the new oil paradigm to last for the foreseeable future and downgraded Legacy Reserves to Neutral and lowered its price target to $9 from $25.
December 15, 2014
11:04 EDTLGCYEnergy MLPs downgraded at Oppenheimer
Subscribe for More Information
10:58 EDTLGCYLegacy Reserves downgraded to Perform from Outperform at Oppenheimer
Subscribe for More Information
06:12 EDTDVADaVita Clinical Research, HealthCare Partners to merge, expand clinical trials
Subscribe for More Information
06:11 EDTDVADaVita Clinical Research, HealthCare Partners to merge, expand clinical trials
December 10, 2014
12:09 EDTYOKUYouku Tudou rises slightly in down market after Credit Suisse upgrade
Subscribe for More Information
09:30 EDTYOKUYouku Tudou upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
December 9, 2014
10:23 EDTAKRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:04 EDTWUBank of China to offer Western Union Money Transfer service
Subscribe for More Information
07:11 EDTAKRXAkorn initiated with Outperform, $50 target at William Blair
William Blair started shares of Akorn with an Outperform rating and $50 price target. The firm says the maker of ophthalmic and hospital-based injectable therapies is one of the fastest-growing companies in the specialty pharmaceuticals sector. William Blair thinks consolidation will likely continue within the specialty/generics market and feels Akorn represents an attractive asset. The stock closed yesterday up 38c to $39.75.
December 8, 2014
11:44 EDTLGCYBreitBurn Energy, Legacy Reserves, Mid-Con Energy downgraded at Wells Fargo
Subscribe for More Information
11:36 EDTLGCYLegacy Reserves downgraded to Market Perform from Outperform at Wells Fargo
11:30 EDTAKRXLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use